PAYER & FORMULARY

Budget Impact Models

What will this cost the payer — and what will it save?

MARKETS
UK (NICE, SMC, AWMSG), Germany (G-BA), France (HAS), Canada (CADTH), US payer and formulary submissions, and further markets on request.
THERAPY AREAS
Oncology · Rare disease · Immunology · Cardiovascular · Infectious disease · Neurology

A Budget Impact Model (BIM) quantifies the financial consequence of adopting a new therapy for a defined payer or healthcare system. It is the primary tool used in formulary submissions, managed entry negotiations, and reimbursement decisions across all major markets.

Is this the right model for you?

What's included

Epidemiological base
eligible patient population sized to the specific payer context
Current treatment mix
market share of existing therapies pre-adoption
Uptake scenarios
modelled adoption curves across a 3–5 year horizon
Cost inputs
drug acquisition, administration, monitoring, and adverse event management
Net budget impact
incremental cost or saving per year and cumulatively
Sensitivity analysis
one-way and probabilistic analyses across key drivers
Full technical report and model documentation

Fee tiers

TIER
FEE
TIMELINE
Rapid BIM
Single market, templated framework, internal use or early payer conversations
 
£10,000–18,000
4–6 weeks
Submission-Ready BIM
Single market, full documentation, payer or formulary submission
 
£20,000–35,000
8–12 weeks
Global BIM
Core global model with up to 3 market adaptations
 
£40,000–65,000
12–16 weeks

All fees are fixed price. Scope, deliverables, and timeline are agreed before work begins. Additional market adaptations available — contact us for a tailored quote.

Ready to discuss your project?

Tell us about your indication, your markets, and your timeline.
We'll come back to you within one working day.

BOOK A SCOPING CALL